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Abstract
Chronic Helicobacter pylori infection is known to be associated with the development of peptic ulcer, gastric cancer and
gastric lymphoma. Currently, the bacterial factors of H. pylori are reported to be important in the development of
gastroduodenal diseases. CagA protein, encoded by the cagA, is the best studied virulence factor of H. pylori. The
pathogenic CagA protein contains a highly polymorphic Glu-Pro-Ile-Tyr-Ala (EPIYA) repeat region in the C-terminal. This
repeat region is reported to be involved in the pathogenesis of gastroduodenal diseases. The segments containing EPIYA
motifs have been designated as segments A, B, C, and D; however the classification and disease relation are still unclear. This
study used 560 unique CagA sequences containing 1,796 EPIYA motifs collected from public resources, including 274
Western and 286 East Asian strains with clinical data obtained from 433 entries. Fifteen types of EPIYA or EPIYA-like
sequences are defined. In addition to four previously reported major segment types, several minor segment types (e.g.,
segment B9,B 99) and more than 30 sequence types (e.g., ABC, ABD) were defined using our classification method. We
confirm that the sequences from Western and East Asian strains contain segment C and D, respectively. We also confirm
that strains with two EPIYA segment C have a greater chance of developing gastric cancer than those with one segment C.
Our results shed light on the relationships between the types of CagAs, the country of origin of each sequence type, and the
frequency of gastric disease.
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Introduction
Helicobacter pylori is a Gram-negative bacterium etiologically
involved in peptic ulcer disease, gastric adenocarcinoma, and
primary gastric B-cell lymphoma [1]. Although infection with H.
pylori almost always results in chronic active gastritis, only a fraction
of those infected develop clinical disease. While this phenomenon
remains unexplained, host genetics, host immune response, and the
relationship of the host response to bacterial virulence factors are
likely to be important factors. A tremendous number of groups have
investigated the roles of putative virulence factors of H. pylori,a n d
the best studied is the CagA protein [2–7]. CagA producing strains
are reported to be associated with severe clinical outcomes,
especially in Western countries [8–11].
CagA is a highly immunogenic protein with a molecular weight
between 120 and 140 kDa [12,13]. Variation in the size of CagA is
due to the presence of a variable number of repeat sequences
located in the 39 region of the gene [12,14–16]. The repeat regions
contain the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif. To characterize
the different sequence patterns in the 39 region, at least four
methods of classification are typically reported. First, the terms
D1, D2, and D3 are used to designate three specific sequences
[12]. Second, sequences are denoted with combinations of R1, R2,
and R3 [14,15]. Third, each EPIYA motif is assigned a motif type
(e.g., EPIYA-A, -B, -C, or –D motif) [17,18,19]. Finally, sequences
are annotated according to segments (20–50 amino acids) flanking
the EPIYA motifs (segments EPIYA-A, -B, -C, or –D) [20–23],
after the identification of the essential CagA phosphorylation sites
as confirmed by mutagenesis during infection and transfection
[24]. Initially, the two Csk binding sites are designated as segments
EPIYA-A and –B, and the Src homology 2 (SH2) domain of Src
homology 2 phosphatase (SHP-2) binding sites in Western and
East Asian type CagA are designated as segments EPIYA-C and
–D, respectively. Here, ‘‘motif’’ and ‘‘segment’’ are used to
designate the five-member sequence (EPIYA) and the short
sequences around the EPIYA motif, respectively (Figure 1).
However, none of the four sequence classification methods work
well with non-standard sequences, and a modified classification
method was deemed necessary.
CagA is encoded by the cagA gene, which is located at one end of
the cag pathogenicity island (PAI) [25]. The cag PAI encodes a type
IV secretion system, by which CagA proteins are delivered into host
cells [26–30]. CagA interacts with various target molecules in
addition to Csk and SHP-2, including Src [31,32] and Abl [33].
Recent study clearly confirmed that almost one dozen of factors
such as SHP-1, Grd2, Grb2, phosphatidylinositol 3-OH kinase
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[34]. Mutations of SHP-2 have been found in various human
malignancies and altered SHP-2 signaling culminates in the
development of gastric adenocarcinoma in genetically engineered
mice [35,36], indicating that SHP-2 is involved in the development
of gastric cancer. Recent studies reported that the East Asian type
CagA containing segments EPIYA-D exhibits stronger binding
activity for SHP-2 and a greater ability to induce morphological
changes in epithelial cells than Western type CagA containing
segments EPIYA-C [17,20,23]. The recent study also showed that
H. pylori strains possessing East Asian type CagA have an ability to
induce higher amounts of interleukin-8 from gastric epithelial cells
than H. pylori strains possessing Western type CagA [37].
Accordingly, East Asian strains are believed to be more virulent
than Western strains, and this might be the reason why the
incidences of gastric cancer in East Asian countries are relatively
higher than those in Europe, North America, and Australia (Data
available at http://www-dep.iarc.fr/). In addition, the incidence of
gastric cancer is reported to be higher in patients infected with
strains carrying multiple EPIYA repeats compared to those infected
with strains of a single repeat [14,15,38,39].
However, there are also controversial reports that the genotypes
(DNA analysis) of the CagA repeat region are not associated with
clinical outcomes [40–43]. This controversy might be due in part
to the fact that genotypes are not necessarily mutations in protein
sequences and that the previous studies of the diversity of CagAs
and the relationship of diseases and protein sequence types used
only limited information, mostly relying on their own data sets.
Indeed, there lacked comprehensive study considering all CagAs
deposited in GenBank (http://www.ncbi.nlm.nih.gov/). More-
over, although CagA EPIYA repeats can be assigned to consensus
sequence types, the existing sequence analyses did not completely
consider the sequence variation patterns in the CagA repeat
region. An in-depth analysis of the non-typical type repeats [15,44]
becomes necessary for addressing the question. In this study, we
used sequence comparison and statistical method to analyze 560
unique CagAs selected from 4,534 CagAs from three data sources.
Our results shed light on the relationships between the types of
CagAs, the country of origin of each sequence type, and the
frequency of gastric disease.
Results and Discussion
EPIYA Motifs Classification
By sequence alignment or pattern comparison, we found that
there were sequences similar to EPIYA (such as EPIYT, ESIYT),
although most sequences contained EPIYA. In this study, the
EPIYA or EPIYA-like sequences were defined as any five member
amino acid sequence with at least three amino acids corresponding
to the sequence, EPIYA (where Y is always constant). By searching
all sequences before data filtering, we obtained 16 types of EPIYA
or EPIYA-like sequences. Of these, 15 types were chosen for
further study because their surrounding sequences were similar to
those of EPIYA (Table 1), indicating that these sequences might
have a function similar to EPIYA. One sequence, MAIYA, from
entry ABA26023 was excluded because the pattern of its flanking
sequences was very different from those of the other 15 types of
EPIYA or EPIYA-like sequences (Table 1). The 15 types listed in
Table 1 are called EPIYA ‘‘motifs’’ for simplicity, in this work.
The frequency of each EPIYA motif in the filtered data set is
listed in Table 1. In total, 1,796 EPIYA motifs were obtained from
the 560 CagAs. On average, each CagA sequence contained
approximately three EPIYA motifs. The three most frequent
EPIYA motifs were EPIYA (1,657/1,796=92.3%), EPIYT (92/1,
796=5.1%), and ESIYA (24/1,796=1.3%).
EPIYA Segments Classification
We categorized the EPIYA segments according to the segments
flanking the EPIYA motifs (Figure 1). In addition to the four major
segments originally designated, EPIYA-A, -B, -C, and –D [20,22],
we designated several minor segments, including EPIYA-B9 and -
B99. Representative examples of these types of segments, derived
from the 560 CagAs, are listed in Table 2 (a few more other types
of segments with frequency less than 10 are given in Table S1. For
simplicity, we refer to segment EPIYA-A, -B, -C, or –D as segment
A, B, C, or D. Segments A, B, B9, and B99 have subscripts C and
D, which indicate that the sequences that contain segments A, B,
B9, and B99 contain segments C and D, respectively (Figure 1).
However, 19 short sequences did not contain either segments C or
D, and we manually assigned a subscript C or D to the segment
type, according to their sequence patterns.
Figure 1. Definitions of segments around EPIYA motif (EPIYA or EPIYA-like sequences). The upper sequences are typical CagA sequences
with Western type and the lower sequences are typical CagA sequences with East Asian type. Segments A, B, B9, and B99have subscripts C and D,
indicating that the sequences containing segments A, B, B9, and B99 contain segments C and D, respectively. For example, the notation EPIYA-AC
signifies segment A from a CagA sequence containing the segment C.
doi:10.1371/journal.pone.0007736.g001
Table 1. Frequencies of the 15 types of EPIYA motifs.
Motif EPIYA EPIYT ESIYA ESIYT EPIYV EHIYA ELIYA EPVYA
Freq. 1657 92 24 7 3 2 2 2
Motif EPIYD EPIYS EPKYA EPRYA ETIYA KPIYA NPIYA Total
Freq. 1 1 1 1 1 1 1 1,796
doi:10.1371/journal.pone.0007736.t001
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sections immediately following EPIYA (Table 2). This was because the
four amino acids, TIDD and TIDF, following EPIYA in segments C
and D, respectively are reported to be important for the binding of
SHP-2 [17,24]. For example, segments B9C and B9D are shorter
versions of segments BC and BD, respectively (Table 2). In segment
B99D, the sequences before EPIYA are similar to those of segment D,
whereasthe sequencesafterEPIYAare similar to those ofsegment BD.
The segment B displayed the biggest change in the five amino
acids; EPIYA motif (Table S2). For the three most frequent motifs
(excluding EPIYA), 89 out of 92 EPIYTs, all 23 ESIYAs, and all 7
ESIYTs, appear in segment B. Interestingly, 88 EPIYT motifs
belong to the segment BC, and only 1 EPIYT belongs to the
segment BD. In contrast, the changes of the five amino acids in
segments A, C, and D were relatively small. In other reports
[18,19], the NPIYA, EPIYT, ESIYA and ESIYT motifs were
named as A9,B 9,B 0 and B09, respectively. However, their
terminology seems to be confusing, otherwise all 15 types of
pseudo EPIYA motifs should have different names. Their motif A9
belonged to our segment A and their B9,B 0, and B09 fell into our
segments B, B9,o rB 99 (Table S2).
CagA Sequence Type Classification
Each CagA sequence was assigned a sequence type consisting of
the names of the EPIYA segments in its sequence (such as ABC or
ABD) (Table S3). Depending on the number of EPIYA segments,
they are termed as AnBnCn or AnBnDn, where ‘‘n’’ is the
repeating motifs and does not have to be equal for A, B, C, and D
types (e.g., ABCCCC). In the event that there was an additional
segment that lacked an EPIYA motif between two neighboring
EPIYA segments, a hyphen was added between the two EPIYA
segments (e.g., A-C, A-D). In total there were 28 segments without
EPIYA motifs between two neighboring EPIYA segments among
the 560 CagAs (Table S3). These 28 interval segments are of
various lengths and contents. In total, 41 different sequence types
were found (Table S4). Among the 41 sequence types, 32 sequence
types are remained (Table 3) after removing the types containing
rare EPIYA segment types (i.e., B99C,C 9,D 9,C 99 and D99). The
majority of the sequences were of types ABD (43%) and ABC
(30%). Interestingly, there were no CagA sequences containing
both segments C and D. This suggests hybridization (recombina-
tion) between Western and East Asian CagA is very rare.
A small number of CagAs were classified differently between
our current study and previous studies (examples shown in Table
S5. For example, the CagA sequence of BAF45291 was classified
as AC in a previous study [44]. However the sequence type was A-
C in our classification, which meant that an interval segment
(VKAKIDQLNQAASGFGNVGQAG) lacking EPIYA-like motif
was present between the sequences A and C. For the CagA
sequence of BAF45283, the sequence type was reported to be
Table 2. Representative segments of EPIYA motifs
a.
Type Freq. Representative sequence
AC 272 KELNAKLGNFNNNNNNGLKN..E EPIYAKVNKKK
AD 295 KELNEKLFGNSNNNNNGLKNNTE EPIYAQVNKKK
BC 262 TGQVASPEE EPIYAQVAKKVNAKIDRLNQIASGLGGVGQAAG
BD 281 TGQATSPEE EPIYAQVAKKVSAKIDQLNEATS
C3 4 3 FPLKRHDKVDDLSKVGRSVSPE EPIYATIDDLGGP
D2 8 4 AINRKIDRINKIASAGKGVGGFSGAGRSASPE EPIYATIDFDEAN
B9C 10 AGQAASPEE EPIYAKVNKKK
B9D 14 AGQATSPEE EPIYAQVNKKK
B99D 19 AINRKIDRINKIASAGKGVGGFSGAGRSANPE EPIYAQVARKVSA-KIDQLNEATS
Total 1,780
aNote: the values in the table are the frequencies of similar sequences, not the number of identical sequences within a sequence type. Other segments of 16 EPIYA
motifs are listed in Table S1.
doi:10.1371/journal.pone.0007736.t002
Table 3. Frequencies of the 32 sequence types
a.
Seq. Type Freq. Seq. Type Freq. Seq. Type Freq. Seq. Type Freq.
ABD 240 AB9-ABD 4 C 2 ABCCCC 1
ABC 167 A-D 4 A 1 A-B0D1
ABCC 51 A-ABD 3 AB9B9BC 1 AB-D 1
ABB0D 16 AB-ABD 2 ABB0BD 1 ABD-ABD 1
AB 15 AB9B9BD 2 AB9BCC 1 ABD-BD 1
ABCCC 10 AB9BD 2 AB9-C 1 ABD-D 1
AB9BC 6 ABCCCCC 2 AB-C 1 A-CCC 1
A-C 5 AB9D 2 ABCB0CC 1 CC 1
aAll sequence types are listed in Table S3. Other sequence types are listed in Table S4.
doi:10.1371/journal.pone.0007736.t003
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classified as ABB0D in this work. The 3
rd segment that differs
between the two studies (D vs. B0) is AINRKIDRINKIASA-
GKGVGGFSGAGRSASPEPIYAQVAKKVSAKIDQLNEATS.
In this segment, the part before the EPIYA motif is similar to
segment D, whereas the part after the EPIYA motif is similar to
segment B. Obviously, this segment is neither D nor B, rather B0,a
variant of segment B (Table 2). Overall, we believe that the
definitions of segment and the sequence classifications used in this
study are more meaningful and accurate than those used in
previous studies.
Each of the 560 CagAs was found to have at least one, and as
many as seven, EPIYA segments (or EPIYA motifs). The
distributions are 3, 27, 416, 86, 23, 3, 2, and 0 for number of
sequences containing 1 through 8 EPIYA segments (Table S6),
respectively. For example, a sequence of type A has only one
EPIYA segment A and a sequence of type ABCCCCC has seven
EPIYA segment, including five repeats of segment C. The majority
(74%=416/560) of sequences had three EPIYA segments.
Detailed Analyses of EPIYA Segments
The EPIYA segment types were defined according to the
segment patterns (Table 2); however the composite amino acids
varied slightly within each segment type. The two most frequent
segments in segments A, B, C and D are shown in Table 4. The
segments of EPIYA-AC or -AD contain from two to eight Ns (Gln)
at the upstream of the pseudo EPIYA-AC or -AD motif. The
segments C and D have higher consensus than segments AC,A D,
BC and BD.
There were obvious differences between segment C and D when
analyzed using the program, WebLogo (Figure 2). The segments
were aligned using BioEdit before they were entered into
WebLogo. As WebLogo had a problem analyzing a column of
aligned sequences if BioEdit had added many spaces, all spaces in
the sequence alignments were replaced by Z (meaning zero or
nothing). In this way, the inserted space (Z) and the minor amino
acids were easily identified. In the alignments, X indicates that an
amino acid was not-available. As shown in Figure 2, the lengths of
segments AC and AD are the same and the sequences of segments
AC and AD are very similar. However the lengths of segments BC
and BD, and the segments C and D are quite different. The
sequences after the stretch of amino acids, QVAKKV, in segments
BC and BD were highly variable, while the sequences of segments
C and D were completely different. Overall, the sequence main
variation between Western and East Asian strains starts after
QVAKKV in segments BC and BD.
The four amino acids TIDD and TIDF following EPIYA motifs
in segments C and D are reported to be important for the binding
SHP-2 [17,24]; therefore, the frequency of the four amino acids
following EPIYA motifs in all EPIYA segments may be useful. As
illustrated in Table S7, the sequences, KVNK and QVNK,
occupy this position in the majority of segments AC and AD,
respectively. QVAK occupied this position in most segments BC
and BD. In the literature [17], the criteria for identifying EPIYA
segments C and D are that the EPIYA motif is followed by TIDD
and TIDF, respectively. However, by sequence pattern compar-
ison, we found that EPIYA also belongs to segment C if it is
followed by TIEE, TIDE, SIDD, TIDG, TIAE, or TIAD. If
EPIYA is followed by TIDS, then it belongs to motif type D. As
shown in Table S2, the segments B, B9, and B99 had the biggest
changes in their composite five amino acids. However, the four
amino acids following the EPIYA motif were most variable in
segment A (Table S7).
Table 4. Two most frequent EPIYA segments
a.
Segment Ratio
AC KELNAKLGNFNNNNNNGLKN..E EPIYAKVNKKK 53/272
AC KELNAKLGNFNNNNNNGLKNS STEPIYAKVNKKK 22/272
AD KELNEKLFGNSNNNNNGLKNNTE EPIYAQVNKKK 53/272
AD XXXXXKLFGNSNNNNNGLKNNTE EPIYAQVNKKK 22/272
BC TGQV VASPEE EPIYAQVAKKVNAKIDRLNQIASGLGGVGQAAG 25/262
BC AGQA AASPEE EPIYAQVAKKVNAKIDRLNQIASGLGGVGQAAG 19/262
BD TGQA ATSPEE EPIYAQVAKKVSAKIDQLNEATS 25/262
BD TGQV VASPEE EPIYAQVAKKVSAKIDQLNEATS 19/262
C FPLKRHDKVDDLSKVGRS SVSPE EPIYATIDDLGGP 144/343
C FPLKRHDKVDDLSKVGRA AVSPE EPIYATIDDLGGP 50/343
D AINRKIDRINKIASAGKGVGGFSGAGRSASPE EPIYATIDFDEA AN 144/343
D AINRKIDRINKIASAGKGVGGFSGAGRSASPE EPIYATIDFDET TN 50/343
aX represents unknown amino acids; the amino acids which are different in two sequences shown are highlighted; Ratio = (Frequency of the type)/(Total frequency).
doi:10.1371/journal.pone.0007736.t004
Figure 2. WebLogos of aligned segments of EPIYA-A, -B, and -
C/D. The numbers of sequences for each WebLogo are indicated. The
sequences were aligned using BioEdit. Z represents space inserted by
BioEdit and X represents unknown amino acids.
doi:10.1371/journal.pone.0007736.g002
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H. pylori strains from different geographic areas are associated
with clear phylogeographic differentiation and H. pylori popula-
tions tend to spread along the lines of human migratory fluxes
[45–50]. Furthermore, several studies concluded that CagA
isoforms with segments C and D are related to Western and East
Asian countries, respectively [14–16]. We tested this hypothesis
using our comprehensive system of CagA classification. The
frequency of each sequence class in individual countries is shown
in Table 5. As expected, all 227 (100%) samples from Western
countries contain EPIYA segment C. In contrast, of 307 sequences
from East Asian countries (Japan, China, Korean, and Viet Nam),
26 (,8%) contain EPIYA segment C instead of segment D.
Interestingly, of the 21 Japanese strains with CagA sequence types
related to segment C, 17 have names beginning with OK (Table
S8), signifying that they were isolated in Okinawa, Japan
(discussed below). The prevalence of sequences containing
segments C and D in Southeast Asian countries (Thailand and
Malaysia) were the same; and all samples from Iran, Kazakhstan
(Kazak), and India were classified as segment C, although they are
Asian countries. Overall, we found that it is largely true that CagA
with sequences segments C and D are related to Western and East
Asian countries, respectively; however, there are some exceptions
for East Asian strains. Southeast Asian countries form the
geographical border between segment C and segment D. The
fact that some East Asian countries have Western type CagA
reflects the partial transmission of H. pylori from Western to East
Asian countries either during the human migration long time ago
or recent transmission.
As mentioned above, there are 21 strains from Japan with
sequences related to EPIYA segment C instead of segment D
(Table 5). The detailed information of these 21 strains is given in
Table S8. Most of these segment C strains were isolated from
Okinawa, which was governed by the United States from the end
of World War II until 1972, and even today there are many US
populations living in Okinawa. These data show that transmission
of H. pylori between different populations may not be a rare event.
In fact, previous reports of native Americans in Peru show that all
H. pylori strains in this population are of the Western type [51],
while only 4 of 17 strains isolated from American primitive, an
isolated group living in the Amazonian jungles of Colombia, were
East Asian type strains [48]. Based on our data, the Western
strains are more easily transferred to East Asian people than the
other way around. Another possibility for Western type CagA in
Okinawa is that the Okinawan CagA is the novel type CagA; the
origin did not come from modern Western people, but came to
Japan long ago. Further studies will be necessary to test this
hypothesis. If it proves true, elucidating the mechanism will be
important for understanding the transmission of H. pylori in human
populations.
Among the 21 strains from Okinawa, 20 contain EPIYA
segment B (Table S8). Of 20 EPIYA motifs in segment B, 15 are
EPIYT and 4 are ESIYT. Comparing this information with the
data in Table S2, we found that the frequencies of the EPIYT and
ESIYT motifs among the sequences of the 21 Okinawa strains are
also relatively high. Detailed analyses for large number of strains
from Okinawa will provide us some information about the roles
and evolution of EPIYA motifs.
Correlation of Sequence Types and Strain Diseases
We were able to obtain clinical information for 433 strains out
of the 560 strains in our data set (Table 6). In our data sheet,
disease G contains gastritis, atrophic gastritis, epigastrial pain,
gastric hyperplastic polyp, non-ulcer dyspepsia, chronic gastritis,
chronic atrophic gastritis, and chronic gastritis-associated dyspep-
sia as well as ‘‘gastris’’, which are regarded as typo of gastritis.
Disease DU and GU (peptic ulcer PU = DU + GU) represent
duodenal ulcer and gastric ulcer, respectively. Disease GC
contains gastric cancer, gastric carcinoma, gastric adenocarcino-
ma, gastric adenoma and adenomatous polyps. Disease MALT
contains MALT lymphoma and MALToma. Disease E represents
esophagitis. Among those 433 samples, 42%, 32%, and 20% of the
patients had diseases G, PU, and GC, respectively, which shows
that there is a potential for selection bias in the sequence samples.
For example, the prevalence of GC is approximately 3% in H.
pylori-positive patients [52]. Nonetheless, the data are useful when
comparing patterns of sequence types among diseases.
We compared three types ABC, ABD and ABCC in relation to
clinical outcomes. Other EPIYA types were excluded since the
number of other minor types was relatively small. As shown in
Table 7, the prevalence of ABCC was 22% (17/[22 + 38 + 17]) in
GC; whereas only 12% (18/[65 + 66 + 18]) in G and 7% (8/[42 +
64 + 8]) in PU. The ratio of ABCC/ABC was therefore
significantly higher in GC (17/22=0.77) than in PU (8/
42=0.19) and G (18/65=0.28) (The calculated chi-square is
8.24 and 6.22, and the probabilities of null hypothesis are less than
0.03 and 0.01, respectively). The data that strains with more
Table 5. Frequency of CagAs with respect to country
a.
Country total #
# of seq. containing
EPIYA-C
# of seq. containing
EPIYA-D
Japan 249 21 228
China 48 4 44
Korea 6 1 5
Viet Nam 4 0 4
Thailand 5 2 3
Malaysia 3 2 1
Iran 5 5 0
India 4 4 0
Kazakhstan 3 3 0
Greece 100 100 0
Italy 34 34 0
Sweden 5 5 0
Ireland 3 3 0
USA 22 22 0
Costa Rica 33 33 0
Colombia 24 24 0
aAustria, Chile, and Germany each have one strain. The country information of
11 sequences or strains is not available.
doi:10.1371/journal.pone.0007736.t005
Table 6. Frequency and percentage of strains of certain type
disease
a.
Disease G DU GU GC E MALT Total
Occurrence 181 90 43 87 21 5 433
Percentage 42% 21% 10% 20% 5% 1% 100%
aThe diseases are designated in the text.
doi:10.1371/journal.pone.0007736.t006
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cancer is consistent with previous studies [15,38]. The ratio of
ABD/ABC was also higher in GC (38/22=1.73) than in PU (64/
42=1.52) and G (66/65=1.02); however the differences were not
statistically significant (The calculated chi-square is 0.14 and 2.79,
and the probabilities of null hypothesis are more than 0.90 and
0.10, respectively).
The 145, 44, and 169 sequences of types ABC, ABD, and
ABCC, respectively, from strains with disease information were
used for phylogenic analysis with ClustalW (http://align.genome.
jp/). The resulting trees are shown in Table S9, S10 and S11 in
the supplementary material. The phylogenetic analysis did not
reveal any association between a particular disease and a specific
CagA sequence.
Conclusion
In this study, 560 unique CagA sequences containing EPIYA-
like motifs were analyzed and in addition to the four previously
reported major CagA segment types (A, B, C and D), we found
that there are various novel types. Our results allow a clearer
classification of the CagA protein sequences and provide a basis
for further molecular studies of the pathogenicity of this important
protein. In addition, we confirmed that strains with two EPIYA
segment C have a greater chance of developing gastric cancer than
those with one segment C. However, we did not find any
association between a particular disease and specific CagA
sequences through phylogenic tree analysis and further studies
with larger number of sequences might be necessary whether the
specific CagA sequences are involved in the development of
clinical outcomes.
Materials and Methods
Data Collection
Three databases, NCBI (National Center for Biotechnology
Information, U.S. National Library of Medicine, www.ncbi.nlm.
nih.gov), UniProtKB/Swiss-Prot (the Swiss Institute for Bioinfor-
matics and the European Bioinformatics Institute, www.ebi.ac.uk/
swissprot/), and DDBJ (DNA Data Bank of Japan, the National
Institute of Genetics, www.ddbj.nig.ac. jp/), were used to obtain
CagA sequencing data. As of Apr 16, 2007, 1,423 entries were
retrieved by searching ‘‘protein’’ at NCBI for ‘‘Helicobacter pylori
CagA’’ with display format of ‘‘GenPept (Full)’’. All related data
were saved to a local disk. 1,034 entries were retrieved by
searching the library, ‘‘UniProtKB/Swiss-Prot & UniProtKB/
TrEMBL’’ at Swiss-Prot for ‘‘Helicobacter pylori CagA’’. The
related data were downloaded in a ‘‘Flat File Format’’. Similarly,
2,077 entries were retrieved by searching ‘‘protein’’ at DDBJ for
‘‘Helicobacter pylori CagA’’. By choosing ‘‘Complete entries’’, the
data were saved as ASCII text on a local disk. The data from
DDBJ include the data from NCBI and UniProtKB/Swiss-Prot.
We found that the sequences from NCBI included all sequences
from UniProtKB/Swiss-Prot and DDBJ; therefore, only the NCBI
data were used for sequence analyses. We have collected clinical
information for 433 strains related to H. pylori CagA. The
information is from our data base (from Y.Y.), the NCBI database,
and the literature [53,54,18,19].
Data Filtering
EPIYA motifs are located in the C-terminus of the CagA
protein. 1,423 entries annotated as CagA in NCBI were
downloaded from GenBank. Two rounds of data filtering were
used to refine the data obtained from NCBI: (1) removing 832
sequences not containing EPIYA or EPIYA-like motifs (Table S12)
and (2) removing 31 redundant sequences (Table S13). Among the
31 sequences, 18 sequences are completely same as others and 13
sequences are parts of others. After the two rounds of filtering, 560
unique CagAs containing EPIYA or EPIYA-like motifs remained
(Table S3).
Statistical Analyses
Chi-square test is used to test the statistical significance of the
difference of strains of sequence types ABCC and ABC in disease
groups GC, PU and G. From Table 7, 17 and 22 strains with
ABCC and ABC types appear in disease GC group, and 8 and 42
strains with ABCC and ABC types appear in disease PU group.
The calculated chi-square (http://math.hws.edu/javamath/ryan/
ChiSquare.html ) is 8.24 from a 262 matrix. Similarly, 17 and 22
strains with ABCC and ABC types appear in disease GC group,
and 18 and 65 strains with ABCC and ABC types appear in
disease G group. The calculated chi-square is 6.22 from a 262
matrix. Then from a chi-square table, the probabilities of null
hypothesis are less than 0.03 and 0.01, respectively, with a df = 1
(df: degree of freedom).
Software for Data Analysis
Home-made program based on MATLAB was used to extract
information from the original data retrieved from NCBI, search
the sequences, sort the sequences according to disease, create files
in FASTA format, etc. BioEdit and WebLogo were used to align
and display protein sequences [55,56]. ClustalW (http://align.
genome.jp/) and TreeView (http://taxonomy.zoology.gla.ac.uk/
rod/treeview. html) were applied to build and view phylogenic
trees.
Supporting Information
Table S1 Full list of representative segments of EPIYA motifs
Note: the values in the table are the frequencies of similar
sequences, not the number of identical type sequences within a
sequence. The highlighted segments are removed in Table 2.
Found at: doi:10.1371/journal.pone.0007736.s001 (0.02 MB
XLS)
Table S2 Distribution of EPIYA motifs in segments A, B, C and
D
Found at: doi:10.1371/journal.pone.0007736.s002 (0.02 MB
XLS)
Table S3 Unique CagA sequences and their sequence types
Found at: doi:10.1371/journal.pone.0007736.s003 (0.10 MB
XLS)
Tabld S4 Frequencies of all sequence types All sequence types
are listed in Table 3S in supplementary.pdf. The highlighted
sequence types are removed in Table 3.
Table 7. EPIYA types and clinical outcomes
a.
Total G PU GC
ABC 129 65, 50%, 1.0 42, 33%, 1.0 22, 17%, 1.0
ABD 168 66, 39%, 0.8 64, 38%, 1.2 38, 23%, 1.3
ABCC 43 18, 42%, 0.8 8, 19%, 0.6 17, 40%, 2.4
aPU = DU + GU. Other diseases are designated in the text. The strains with
unavailable disease information are not included.
doi:10.1371/journal.pone.0007736.t007
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XLS)
Table S5 Comparison of sequence classifications in literatures
[1] T.Uchida, R. Kanada, Y. Tsukamoto, N. Hijiya, K. Matsuura,
S. et al., Cancer Sci. 98 (2007) 521–528. [2] M. Naito, T.
Yamazaki, R. Tsutsumi, H. Higashi, K. Onoe, et al., Gastroen-
terology 130 (2006) 1181–1190.
Found at: doi:10.1371/journal.pone.0007736.s005 (0.02 MB
XLS)
Table S6 Distribution of multiple repeats of EPIYA segments
Found at: doi:10.1371/journal.pone.0007736.s006 (0.02 MB
XLS)
Table S7 Distribution of the first four amino acids following
EPIYA motifs
Found at: doi:10.1371/journal.pone.0007736.s007 (0.02 MB
XLS)
Table S8 Samples (from Japan) related to EPIYA-C
Found at: doi:10.1371/journal.pone.0007736.s008 (0.02 MB
XLS)
Table S9 The phylogenic tree of fragments ABC
Found at: doi:10.1371/journal.pone.0007736.s009 (0.40 MB
XLS)
Table S10 The phylogenic tree of fragments ABCC
Found at: doi:10.1371/journal.pone.0007736.s010 (0.11 MB
XLS)
Table S11 The phylogenic tree of fragments ABCC
Found at: doi:10.1371/journal.pone.0007736.s011 (0.40 MB
XLS)
Table S12 The information of sequences without EPIYA-like
motif
Found at: doi:10.1371/journal.pone.0007736.s012 (0.13 MB
XLS)
Table S13 The information of redundant sequences *The
sequences under ANo2 are completely same as or cover that
under Ano. **Length2 are the length of sequences under ANo2.
Found at: doi:10.1371/journal.pone.0007736.s013 (0.02 MB
XLS)
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